Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study

Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study

Abstract Background Prognostic value or clinical implications of fluid status monitoring in liver cirrhosis are not fully elucidated. Tolvaptan, an orally available, selective vasopressin V2-receptor antagonist approved for hyponatremia in the United States and European Union. It is also used for ci...

Full description

Bibliographic Details
Main Authors: Shunsuke Shiba, Po-sung Chu, Nobuhiro Nakamoto, Karin Yamataka, Nobuhito Taniki, Keisuke Ojiro, Akihiro Yamaguchi, Rei Morikawa, Aya Yoshida, Akihiko Ikura, Hirotoshi Ebinuma, Hidetsugu Saito, Takanori Kanai
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Gastroenterology
Subjects:
Ascites
Impedance
Liver cirrhosis
Vasopressin antagonism
Online Access:http://link.springer.com/article/10.1186/s12876-020-01205-2

Internet

http://link.springer.com/article/10.1186/s12876-020-01205-2

Similar Items